Advanced Solid Tumors

Who we are

  • April 24, 2024
    Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
  • January 10, 2024
    A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
  • December 8, 2022
    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
  • April 5, 2022
    Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
  • April 5, 2022
    TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
  • April 5, 2022
    REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
  • April 5, 2022
    Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)